Metachronous primary uterine cancer surgically resected during Crizotinib treatment in a ALK-rearranged advanced lung adenocarcinoma

Rearrangements of the anaplastic lymphoma kinase (ALK) gene are present in 3% to 7% of non-small-cell lung cancers (NSCLCs). Patients harboring ALK rearrangements show very favourable outcomes if treated with targeted agents, among which crizotinib is the first and best studied. Crizotinib, an oral...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Transl Lung Cancer Res
Κύριοι συγγραφείς: Catino, Annamaria, Misino, Andrea, Scattone, Anna, Caldarola, Lucia, Petroni, Stella, Logroscino, Antonio, Montagna, Elisabetta Sara, Serio, Gabriella, Simone, Giovanni, Galetta, Domenico
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: AME Publishing Company 2016
Θέματα:
Case Report
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4758975/
https://ncbi.nlm.nih.gov/pubmed/26958511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2016.01.04
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια